Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy. By continuing to use this site without changing your settings you consent to our use of cookies in accordance with our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
Sign In



Contact details

Allen & Overy LLP
52 avenue Hoche

Telephone icon+33 (0)1 40 06 50 33
Send email

Download contact detailsDownload contact details View officeView office

  Laetitia Benard



Laëtitia is a partner of the Intellectual Property and Litigation department in Paris. She leads the Paris IP practice and is co-head of Allen & Overy's Life Sciences Group worldwide. She has a wealth of expertise in all intellectual property areas including patents, trademarks, copyright and unfair competition issues, both contentious and non-contentious. She also advises on regulatory issues and contracts.

Laëtitia frequently publishes in the intellectual property field. Her publications include "Interim injunctions over patents – The French practice" in Managing Intellectual Property; "Overview of Life Sciences law in France" in Chambers Life Sciences Guide 2013; and the “France” chapter in International Copyright Law book, Global Law & Business.

"Laëtitia Bénard heads the IP and litigation department: 'She is incredibly capable, knows her cases extremely well, anticipates questions before they arise and has a complete grasp of all aspects of IP litigation issues in France'.” IAM Patent 1000 – France, 2017

"Practice head Laëtitia Bénard is ‘very impressive and the must-use lawyer in the life sciences area’." Legal 500 – EMEA 2017 – Intellectual Property: Patents - France

"Laëtitia Bénard excels in all aspects of IP with a particular focus on the life sciences sector."  Chambers & Partners Europe 2017 - Intellectual Property – France

"Laëtitia Bénard is described as a 'very present and important' practitioner in the market. She has particular expertise in the life sciences sector." Who's Who Legal - France 2017

"Practice head Laetitia Benard is widely respected on the market. both in Paris and worldwide, for her strong capabilities as a patent litigator. Her 'deep knowledge of the life sciences sector' continues to be a plus for clients." Chambers & Partners Europe 2016 – Intellectual Property – France

"Practice head Laëtitia Bénard has ‘an excellent knowledge of the industry, the courts and the law’, and is ‘an advocate for bringing France to the forefront of modern pharmaceutical patent practice’." Legal 500 – EMEA 2016 – Intellectual Property: Patents - France

“Laëtitia is a fearless advocate for IP rights. Her written and oral advocacy is deeply persuasive. 'I can’t think why a pharma firm in France would use anyone else', says on impressed client. 'She is the best in France '." IP Stars - Managing IP – Patent contentious 2016-2017

Professional qualifications

Admitted to the Bar, Paris, 2000

Academic qualifications

Post Graduate Degree, Industrial Property, University of Paris II Panthéon Assas, 1999

Post Graduate Degree, French Civil Law, University of Paris I Panthéon Sorbonne, 1998

Published work

‘Brexit’: time is of the essence for life sciences innovators – LSIPR (Life Sciences Intellectual Property Review) – June 2016

La juridiction unifiée du brevet (JUB) : un atout indéniable pour l'Europe, La Lettre des juristes d'affaires, July 2014

La juridiction unifiée du brevet (JUB) reçoit un soutien croissant des entreprises, Option Droit et Finance, July 2014 co-authored with David Por

France’s Biosimilar law may set trend inside the EU, Law 360, February 2014, co-authored with Eveline Van Keymeulen

L’Acte II de l’exception culturelle sur la scène du numérique, Les Echos, June 2013

"France" chapter, International Copyright Law book, Global Law & Business, May 2013, co-authored with Alexandre Rudoni and Olivia Klimis

Overview of Life Sciences law in France, Chambers Life Sciences Guide 2013, co-authored with Olivier Fréget, David Por and Olivia Klimis

Interim injunctions over patents, The French practice, Managing Intellectual Property, co-authored with Olivia Klimis

Choisir la stratégie juridique adéquate pour valoriser sa marque - Décryptage avec Laëtitia Bénard, Les Echos, December 2012

Comparative Advertising for generics in Germany and France after L’Oréal v Bellure, PTMG Law Lore & Practice, December 2012, co-authored with Oscar Benito, Rainer Kaase and Ralf Möller

Il faut sauver le projet de brevet unitaire européen, Option Droit & Affaires, September 2012, co-authored with Olivia Klimis

Preliminary injunctions in Europe: an overview in the field of patents, The Handbook of European IP Management, May 2012

Trade secrets protection: a comparative overview, The Handbook of European IP Management, May 2012, co-authored with  Benjamin Bai and Paul B. Keller

Why France is a good forum for preliminary injunctions in patent matters, Global Business Magazine, April 2012

Supplementatry protection certificates: CJEU provides welcome clarifications, Who's Who Legal, Life Sciences, April 2012, co-authored with Olivia Klimis

Trade secrets protection, Commerce International, April 2012

L'arrêt DHL/Chronopost de la CJUE du 12 avril 2011 : une injonction communautaire peut être obtenue dans les limites de l'atteinte aux fonctions de la marque, Revue Lamy Droit de l'immatériel, August/September 2011, co-authored with Alexandra Abello

Competition, Public Health, Innovation and Drugs, LGDJ, 2010, under the supervision of Marie-Anne Frison-Roche

Generic drugs and IP law, Lamy Droit de la Santé, 2002, 2004 and 2008

Question 202 of the AIPPI French group on "The impact of public health issues on exclusive patents rights", September 2008

The DADVSI law regarding television: three steps backward for right owners?, Legipresse, May 2007, co-authored with Alexandre Rudoni

Rights owners and users fail to agree on reform, Managing Intellectual Property, June 2006, co-authored with Alexandre Rudoni

How to prepare the businessmen in the biotechnology sector for the cession of their firm, Bio Futur, October 2005, co-authored with Alexandre Rudoni

Find a lawyer

  • Expertise

  • Search Clear

  • Add comment (optional)